摘要 |
<p>Disclosed is a novel LXRß agonist which is useful as a prophylactic and/or therapeutic agent for arteriosclerosis (e.g., atherosclerosis, arteriosclerosis induced by diabetes), dyslipidemia, hypercholesterolemia, a lipid-related disease, an inflammatory disease that is a disease caused by an inflammatory cytokine, a skin disease (e.g., allergic dermatitis), diabetes or Alzheimer's disease. Specifically disclosed is a 1,3-dihydroisobenzofuran derivative represented by general formula (1), a salt thereof, or a solvate of the derivative or the salt.</p> |
申请人 |
KOWA COMPANY, LTD.;OKUDA, AYUMU;MATSUDA, TAKAYUKI;MIURA, TORU;YAMAZAKI, KOICHI;YAMAGUCHI, YUKI;KOURA, MINORU;KUROBUCHI, SAYAKA;WATANABE, YUUICHIROU;SHIBUYA, KIMIYUKI |
发明人 |
OKUDA, AYUMU;MATSUDA, TAKAYUKI;MIURA, TORU;YAMAZAKI, KOICHI;YAMAGUCHI, YUKI;KOURA, MINORU;KUROBUCHI, SAYAKA;WATANABE, YUUICHIROU;SHIBUYA, KIMIYUKI |